NCT05166642

Brief Summary

Total Joint Arthroplasty (TJA) has become one of the most performed elective procedures. While the results of this procedure are often consistent with high patient satisfaction and return-to-function, wound-related complications can contribute to high-cost "bundle busters". Following surgery, wound drainage or other wound complications can lead to increased cost and decreased patient satisfaction. Secure wound closure is an important step in preventing wound-related complications. The surgical incision should be closed in a manner that prevents the wound edges from separating which could lead to possible drainage and bacterial contamination of the incision. Traditional incision closure following TJA includes sutures. These sutures are then removed in the office. BandGrip is a wound closure device that can be used to approximate skin edges of wounds from surgical incisions and traumatic lacerations. It is a bandage-type patch with several small skin anchors that are used to hold the skin edges together. The clear microanchors are 0.029 inches in height and do not puncture through the dermis. There is no need for medical removal as the patient can remove the bandage.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 22, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

September 11, 2023

Status Verified

September 1, 2023

Enrollment Period

2.7 years

First QC Date

December 7, 2021

Last Update Submit

September 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of patients with wound healing complications

    All wound-related complication following surgery

    From time of surgery to 30 days post-op

Secondary Outcomes (1)

  • Closure time of surgical wound

    Procedure (The time from the first skin pass with the suture needle until the time the last suture knot is tied will be recorded in seconds)

Study Arms (2)

Bandgrip Micro-Anchor Skin Closure

ACTIVE COMPARATOR
Device: Bandgrip Micro-Anchor Wound Closure

Standard of Care wound closure

ACTIVE COMPARATOR

Standard Monocryl suture closure

Device: Suture closure

Interventions

This treatment group will utilize a suture closure technique for the deep dermal layers with Bandgrip being applied to the most superficial layer of the surgical incision

Bandgrip Micro-Anchor Skin Closure

This treatment gourd will utilize suture closure technique for all layers of the surgical incision.

Standard of Care wound closure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is male or female greater than 18 years of age
  • Scheduled to undergo primary total knee or total hip replacement
  • Able to read and comprehend informed consent form and comply with the follow-up evaluation schedule

You may not qualify if:

  • Prior surgical incision or scar in close proximity of the proposed incision (\<2 cm).
  • Local skin conditions such as dermatitis, eczema, or psoriasis.
  • Active or previous infection in the skin or the hip or knee to be operated.
  • Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical corticosteroid use
  • Subject has a recent history of bleeding, coagulation and/or clotting disorders
  • Subject has a known allergy to BandGrip material (polycarbonate)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rothman Orthopaedics

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

Sutures

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Surgical Fixation DevicesSurgical EquipmentEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2021

First Posted

December 22, 2021

Study Start

March 8, 2021

Primary Completion

December 1, 2023

Study Completion

January 1, 2024

Last Updated

September 11, 2023

Record last verified: 2023-09

Locations